Abstract
BackgroundRheumatoid arthritis associated interstitial lung disease (RA-ILD) is a common extra-articular manifestation and acute exacerbation (AE) is sometimes critical. While the prognosis of RA has been improved with biologic agents...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
